Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension,
0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating
inflammation in the eye.